Darrick Carter, Ph.D.

CEO
PAI Lifesciences

Poster(s):

• Tu183 - Bridging Studies with cGMP RBmHAXT(∆cys), a Tetravalent Vaccine for Lymphatic Filariasis, for Clinical Development
  Tuesday, June 24, 2025

  6:00pm - 7:30pm East Coast USA Time